ClinicalTrials.gov record
Completed Phase 3 Interventional

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

ClinicalTrials.gov ID: NCT00083954

Public ClinicalTrials.gov record NCT00083954. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 2:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Confirmatory Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression

Study identification

NCT ID
NCT00083954
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
530 participants

Conditions and interventions

Interventions

  • Quetiapine Fumarate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Not listed
Completion
Jul 31, 2005
Last update posted
Jan 3, 2013

2004 – 2005

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Scottsdale Arizona
Research Site Cerritos California
Research Site Garden Grove California
Research Site San Diego California
Research Site Torrance California
Research Site Jacksonville Florida
Research Site Maitland Florida
Research Site Orlando Florida
Research Site Winter Park Florida
Research Site Boise Idaho
Research Site Oak Brook Illinois
Research Site Overbrook Terrace Illinois
Research Site Shreveport Louisiana
Research Site Baltimore Maryland
Research Site Clementon New Jersey
Research Site Moorestown New Jersey
Research Site Albuquerque New Mexico
Research Site Brooklyn New York
Research Site New York New York
Research Site Staten Island New York
Research Site Raleigh North Carolina
Research Site Cincinnati Ohio
Research Site Dayton Ohio
Research Site Oklahoma City Oklahoma
Research Site Portland Oregon
Research Site Philadelphia Pennsylvania
Research Site Pittsburgh Pennsylvania
Research Site Charleston South Carolina
Research Site Memphis Tennessee
Research Site Austin Texas
Research Site Houston Texas
Research Site Salt Lake City Utah
Research Site Bellevue Washington
Research Site Kirkland Washington
Research Site Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00083954, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2013 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00083954 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →